sTLR2 RAPID Overview & Features

The IMIWN sTLR2 RAPID Test - Advanced Immunological Measurement at the Point of Care

The IMIWN sTLR2 RAPID Test is an in vitro diagnostic (IVD) immunochromatographic (lateral flow) assay designed for the rapid, semi-quantitative measurement of human soluble Toll-like Receptor 2 (sTLR2) in plasma. Developed with immunologists and clinicians in mind, this test provides insights into innate immune activation and systemic inflammation.

Key Features and Benefits for Immunological Assessment

  • Rapid Results: Semi-quantitative results in 10 minutes, facilitating timely immunological assessment in critical situations
  • No Hardware: Results are easily read by eye without the need for further equipment
  • Minimal Sample Volume: Requires only a 20µL sample of whole blood, plasma or serum, for patient comfort and laboratory efficiency.
  • Proprietary Monoclonal Antibodies: Utilises our proprietary specific sTLR2 monoclonal antibodies, ensuring robust and reliable detection of the target biomarker
  • Simple Lateral Flow Format: Designed for ease of use, the convenient lateral flow format minimizes procedural complexity, making it suitable for diverse laboratory and point-of-care settings
  • Quality Assured: Developed and manufactured in the UK under a fully certified medical device quality assurance system (ISO13485) and UKCA certified, ensuring adherence to stringent quality and regulatory standards.

Each kit contains 10 individual test devices

View assay performance and validation for the IMIWN sTLR2 RAPID test.